Pharmaceutical Price-Gouging: An Analysis of Maryland's Efforts to Regulate Unconscionable Increases in the Prices of Generic Drugs

Authors

  • Harry Shanmugam Boston College

Keywords:

pharmaceutical law, price-gouging, maryland, regulation, drug prices, pharmaceutical price-gounging

Abstract

Shanmugam examines the relevant and urgent issue of exorbitantly high pharmaceutical prices, particularly as it relates to patent law. Shanmugam’s essay starts by outlining the Hatch-Waxman Act and its implications, and then presents a balanced analysis of the effectiveness of Maryland’s HB 631 law to curb price-gouging of generic drugs.

References

N/A

Downloads

Published

04/21/2020

How to Cite

Harry Shanmugam. (2020). Pharmaceutical Price-Gouging: An Analysis of Maryland’s Efforts to Regulate Unconscionable Increases in the Prices of Generic Drugs. Bellarmine Law Society Review, 9(2). Retrieved from https://ejournals.bc.edu/index.php/blsr/article/view/12243

Issue

Vol. 9 No. 2 (2019): Bellarmine Pre-Law Review

Section

Articles

License

Copyright (c) 2020 Bellarmine Law Society Review

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Please follow the link for further Copyright and License Information.